Frisch SM - Search Results

1

Grainyhead-like-2 confers NK-sensitivity through interactions with epigenetic modifiers.

MacFawn I, Wilson H, Selth LA, Leighton I, Serebriiskii I, Bleackley RC, Elzamzamy O, Farris J, Pifer PM, Richer J, Frisch SM. MacFawn I, et al. Among authors: frisch sm. Mol Immunol. 2019 Jan;105:137-149. doi: 10.1016/j.molimm.2018.11.006. Epub 2018 Nov 30. Mol Immunol. 2019. PMID: 30508726 Free PMC article.

2

Roles of Grainyhead-like transcription factors in cancer.

Frisch SM, Farris JC, Pifer PM. Frisch SM, et al. Oncogene. 2017 Nov 2;36(44):6067-6073. doi: 10.1038/onc.2017.178. Epub 2017 Jul 17. Oncogene. 2017. PMID: 28714958 Review.

3

Grainyhead-like 2 Reverses the Metabolic Changes Induced by the Oncogenic Epithelial-Mesenchymal Transition: Effects on Anoikis.

Farris JC, Pifer PM, Zheng L, Gottlieb E, Denvir J, Frisch SM. Farris JC, et al. Among authors: frisch sm. Mol Cancer Res. 2016 Jun;14(6):528-38. doi: 10.1158/1541-7786.MCR-16-0050. Epub 2016 Apr 15. Mol Cancer Res. 2016. PMID: 27084311 Free PMC article.

4

Grainyhead-like 2 inhibits the coactivator p300, suppressing tubulogenesis and the epithelial-mesenchymal transition.

Pifer PM, Farris JC, Thomas AL, Stoilov P, Denvir J, Smith DM, Frisch SM. Pifer PM, et al. Among authors: frisch sm. Mol Biol Cell. 2016 Aug 1;27(15):2479-92. doi: 10.1091/mbc.E16-04-0249. Epub 2016 Jun 1. Mol Biol Cell. 2016. PMID: 27251061 Free PMC article.

5

Suppression of the epithelial-mesenchymal transition by Grainyhead-like-2.

Cieply B, Riley P 4th, Pifer PM, Widmeyer J, Addison JB, Ivanov AV, Denvir J, Frisch SM. Cieply B, et al. Among authors: frisch sm. Cancer Res. 2012 May 1;72(9):2440-53. doi: 10.1158/0008-5472.CAN-11-4038. Epub 2012 Feb 29. Cancer Res. 2012. PMID: 22379025 Free PMC article.

6

Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2.

Cieply B, Farris J, Denvir J, Ford HL, Frisch SM. Cieply B, et al. Among authors: frisch sm. Cancer Res. 2013 Oct 15;73(20):6299-309. doi: 10.1158/0008-5472.CAN-12-4082. Epub 2013 Aug 13. Cancer Res. 2013. PMID: 23943797 Free PMC article.

7

Type I interferons and related pathways in cell senescence.

Frisch SM, MacFawn IP. Frisch SM, et al. Aging Cell. 2020 Oct;19(10):e13234. doi: 10.1111/acel.13234. Epub 2020 Sep 12. Aging Cell. 2020. PMID: 32918364 Free PMC article. Review.

8

A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition.

Kumar S, Park SH, Cieply B, Schupp J, Killiam E, Zhang F, Rimm DL, Frisch SM. Kumar S, et al. Among authors: frisch sm. Mol Cell Biol. 2011 Oct;31(19):4036-51. doi: 10.1128/MCB.01342-10. Epub 2011 Jul 11. Mol Cell Biol. 2011. PMID: 21746881 Free PMC article.

9

CD44S-hyaluronan interactions protect cells resulting from EMT against anoikis.

Cieply B, Koontz C, Frisch SM. Cieply B, et al. Among authors: frisch sm. Matrix Biol. 2015 Oct;48:55-65. doi: 10.1016/j.matbio.2015.04.010. Epub 2015 Apr 30. Matrix Biol. 2015. PMID: 25937513 Free PMC article.

10

Mechanisms and context underlying the role of autophagy in cancer metastasis.

Dower CM, Wills CA, Frisch SM, Wang HG. Dower CM, et al. Among authors: frisch sm. Autophagy. 2018;14(7):1110-1128. doi: 10.1080/15548627.2018.1450020. Epub 2018 Jun 4. Autophagy. 2018. PMID: 29863947 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters